Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Detrusitol and Omnic for ureteral stent-related discomfort
IRCT20190624043991N13Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tolterodine and tamsulosin in ureterolithiasis, sponsored by Tehran University of Medical Sciences. Started Dec 2019; status: completed.
02
Drugs
tolterodinetamsulosin
03
Conditions
ureterolithiasis
Beyond the preview
Go deeper on IRCT20190624043991N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190624043991N13.